[HTML][HTML] The pancreatic stellate cell: a star on the rise in pancreatic diseases

MB Omary, A Lugea, AW Lowe… - The Journal of clinical …, 2007 - Am Soc Clin Investig
Pancreatic stellate cells (PaSCs) are myofibroblast-like cells found in the areas of the
pancreas that have exocrine function. PaSCs are regulated by autocrine and paracrine …

Chronic pancreatitis: challenges and advances in pathogenesis, genetics, diagnosis, and therapy

H Witt, MV Apte, V Keim, JS Wilson - Gastroenterology, 2007 - Elsevier
Chronic pancreatitis (CP) is characterized by progressive pancreatic damage that eventually
results in significant impairment of exocrine as well as endocrine functions of the gland. In …

Pathologic evaluation and reporting of intraductal papillary mucinous neoplasms of the pancreas and other tumoral intraepithelial neoplasms of pancreatobiliary tract …

V Adsay, M Mino-Kenudson, T Furukawa… - Annals of …, 2016 - journals.lww.com
Background: There are no established guidelines for pathologic diagnosis/reporting of
intraductal papillary mucinous neoplasms (IPMNs). Design: An international …

Italian consensus guidelines for chronic pancreatitis

L Frulloni, M Falconi, A Gabbrielli, E Gaia… - Digestive and Liver …, 2010 - Elsevier
This paper gives practical guidelines for diagnosis and treatment of chronic pancreatitis.
Statements have been elaborated by working teams of experts, by searching for and …

Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized …

DC Whitcomb, GA Lehman, G Vasileva… - Official journal of the …, 2010 - journals.lww.com
OBJECTIVES: Pancreatic-enzyme replacement therapy (PERT) is the standard of care to
prevent maldigestion, malnutrition, and excessive weight loss in patients with exocrine …

[HTML][HTML] A proposal for a new clinical classification of chronic pancreatitis

MW Büchler, ME Martignoni, H Friess… - BMC …, 2009 - Springer
Background The clinical course of chronic pancreatitis is still unpredictable, which relates to
the lack of the availability of a clinical classification. Therefore, patient populations cannot be …

Partial pancreatic resection for pancreatic malignancy is associated with sustained pancreatic exocrine failure and reduced quality of life: a prospective study

CM Halloran, TF Cox, S Chauhan, MGT Raraty… - Pancreatology, 2012 - karger.com
Objectives: Pancreatic resection for cancer may produce pancreatic exocrine insufficiency
(PEI), which is poorly understood. This study examined the coefficient of fat absorption …

A 6‐month, open‐label clinical trial of pancrelipase delayed‐release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or …

N Gubergrits, E Malecka‐Panas… - Alimentary …, 2011 - Wiley Online Library
Aliment Pharmacol Ther 2011; 33: 1152–1161 Summary Background Pancreatic enzyme
replacement therapy (PERT) is necessary to prevent severe maldigestion and unwanted …

Total pancreatectomy with islet autotransplantation: summary of an NIDDK workshop

MD Bellin, A Gelrud, G Arreaza-Rubin, TB Dunn… - Annals of …, 2015 - journals.lww.com
A workshop sponsored by the National Institute of Diabetes and Digestive and Kidney
Diseases focused on research gaps and opportunities in total pancreatectomy with islet …

[HTML][HTML] Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century

T Trang, J Chan, DY Graham - World journal of gastroenterology …, 2014 - ncbi.nlm.nih.gov
Restitution of normal fat absorption in exocrine pancreatic insufficiency remains an elusive
goal. Although many patients achieve satisfactory clinical results with enzyme therapy, few …